Skip to main contentAI and Advanced
/
SANOFICONR · NSEMarket ticker unavailable · configure an authorised index feed
SA
NSE · Equity shares · Biotechnology & Drugs-98.10 · -2.40%
Sanofi Consumer Healthcare India SANOFICONR
NSE:INR 3,981.9
BSE:INR 4,558.25
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for SANOFICONR
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 4,080
Day rangeINR 3,971 — INR 4,039.3
52-week rangeINR 3,971 — INR 5,357
Volume1,967
Market cap10,499.09
P/E39.8
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)878.4
Net Income (INR Cr)240.1
P/E Ratio39.8
Book Value150.93
EPS102.12
Price/BV26.38Computed
Research path: Interpret Sanofi Consumer Healthcare India's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
SANOFICONRSanofi Consumer Healthcare India1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 547 | 431.3 | 345.4 |
| Accumulated Depreciation Total | -14.3 | -6 | -2.5 |
| Cash Equivalents | 371.3 | 322.9 | 0 |
| Other Liabilities Total | 17.5 | 11.1 | 7.9 |
| Accrued Expenses | 24.6 | 24.4 | 12.9 |
| Common Stock Total | 23 | 23 | 2 |
| Prepaid Expenses | 1.2 | 2 | 0 |
| Total Assets | 547 | 431.3 | 345.4 |
| Current Portof LT Debt/Capital Leases | 7.7 | 3.7 | 0 |
| Cash | 3.9 | 4 | 1.6 |
| Total Equity | 384 | 273 | 207.6 |
| Retained Earnings(Accumulated Deficit) | 361 | 250 | 182.6 |
| Total Common Shares Outstanding | 2.3 | 2.3 | 2.3 |
| Property/Plant/Equipment Total-Gross | 49.4 | 33.9 | 4.5 |
| Tangible Book Valueper Share Common Eq | 166.39 | 117.71 | 87.75 |
| Total Liabilities | 163 | 158.3 | 137.8 |
| Total Debt | 24.8 | 20.3 | 0 |
| Short Term Investments | 0 | Not available | Not available |
| Cashand Short Term Investments | 375.2 | 326.9 | 1.6 |
| Total Receivables Net | 56 | 21.9 | 237 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 |
| Accounts Receivable-Trade Net | 29.6 | 13.7 | 31.6 |
| Property/Plant/Equipment Total-Net | 35.1 | 27.9 | 2 |
| Total Current Liabilities | 128.4 | 130.6 | 129.9 |
| Total Inventory | 61.9 | 40.9 | 96.6 |
| Accounts Payable | 79.6 | 70.3 | 60 |
| Other Currentliabilities Total | 16.5 | 32.2 | 57 |
| Total Long Term Debt | 17.1 | 16.6 | 0 |
| Intangibles Net | 0.8 | 1.9 | 5.5 |
| Other Long Term Assets Total | 11 | 8.6 | 1.9 |
| Note Receivable-Long Term | 5.8 | 1.2 | 0.8 |
| Total Current Assets | 494.3 | 391.7 | 335.2 |
| Capital Lease Obligations | 17.1 | 16.6 | 0 |
| Other Equity Total | Not available | 0 | 23 |
Fundamentals
Valuation and ratios
Margins
Operating Margin 12m35.77
Net Profit Margin 12m28.01
Yield
Dividend Yield %1.65
Valuation
Price to Sale Ratio11.95
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk35.01
Analyst consensus
ConsensusStrong Buy
Consensus score1.00
Analyst opinions1
Strong Sell count0
Sell count0
Hold count0
Buy count0
Strong Buy count1
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | INR 1,944 | 4.66 L | 38.4 | — |
| Divi's Laboratories | INR 8,291.55 | 2.20 L | 73.32 | — |
| Torrent Pharmaceuticals | INR 4,965 | 1.89 L | 72.73 | — |
| Cipla | INR 1,475 | 1.19 L | 27.57 | — |
| Zydus Lifesciences | INR 1,106.25 | 1.10 L | 21.19 | — |
Shareholding
Ownership
- Promoter
- 71.27%
- FII
- 2.60%
- MF
- 13.01%
- Other
- 13.12%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Sanofi Consumer Healthcare India Ltd Shows Mildly Bullish Momentum Amid Mixed Technical Signals - MarketsMojoMarket news · 17 Jul 2026, 8:24 am
Sanofi Consumer Healthcare India Ltd Shows Mildly Bullish Momentum Amid Mixed Technical Signals MarketsMojo
Sanofi Consumer Healthcare India Ltd Faces Technical Momentum Shift Amid Sideways Trend - MarketsMojoMarket news · 15 Jul 2026, 8:43 am
Sanofi Consumer Healthcare India Ltd Faces Technical Momentum Shift Amid Sideways Trend MarketsMojo
Sanofi appoints PwC as statutory auditor for five-year term - scanx.tradeMarket news · 30 Jun 2026, 12:30 pm
Sanofi appoints PwC as statutory auditor for five-year term scanx.trade
VIYASH Stock Price and Chart — NSE:VIYASH - TradingViewMarket news · 24 Jun 2026, 12:30 pm
VIYASH Stock Price and Chart — NSE:VIYASH TradingView
The role of content and consumer education in healthcare marketing - Exchange4MediaMarket news · 16 Jun 2026, 12:30 pm
The role of content and consumer education in healthcare marketing Exchange4Media
Mega Dividend Alert! THIS Pharma Stock Is Paying 750% Dividend | How To Get Eligible? - GoodreturnsMarket news · 16 Jun 2026, 12:30 pm
Mega Dividend Alert! THIS Pharma Stock Is Paying 750% Dividend | How To Get Eligible? Goodreturns
Corporate actions
Events
- board MeetingsQuarterly Results
- dividendRs.75.0000 per share(750%)Final Dividend
- board MeetingsQuarterly Results
- annual General MeetingPOM
- board MeetingsAudited Results & Final Dividend
- board MeetingsQuarterly Results
- annual General MeetingPOM
- board MeetingsQuarterly Results
Rusaka Markets Community
Discussion and sentiment for Sanofi Consumer Healthcare India
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Sanofi Consumer Healthcare India Limited is an India-based company. It is engaged in the business of manufacturing, producing, processing, marketing, formulating, buying, trading, storing, packing, selling, distributing, importing, exporting, providing consultancy and otherwise dealing in all kinds of varieties of pharmaceuticals, especially consumer healthcare products, including: basic drugs; drug intermediates; chemical, medical, biological and electrolytic drugs, ingredients, Medicare, preparations and compositions; medicines, preparations and formulations in all or any forms, including formulations in which various drugs are processed; patents, medicines, drugs enzymes, fermentations and generic products, vitamin and vitamins products tonic, food products, nutritional products, products in therapies such as pain care, allergy, digestive health, cough & cold, sleep, general wellness and hormones and hormone products, and ingredients of every kind and other articles, and compounds.
Company facts
- Industry
- Biotechnology & Drugs
- Sector
- Biotechnology & Drugs
- NSE Code
- SANOFICONR
- BSE Code
- 544250
Questions
Stock FAQ
What is the symbol and ISIN of Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India has the symbol SANOFICONR and ISIN - INE0UOS01011.
What is the current price of Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India is currently trading at INR 3,981.90.
What are the year high and year low of Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India has a year high of INR 5,357.00 and a year low of INR 3,971.00.
What is the market capitalization of Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India has a market capitalization of INR 10,499.09 crore.
What is the P/E ratio of Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India has a P/E ratio of 39.80.
What is the dividend yield of Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India has a dividend yield of 1.65%.
How is the financial performance of Sanofi Consumer Healthcare India based on revenue, net income, and EPS?
Sanofi Consumer Healthcare India has revenue of INR 878.40 crore, net income of INR 240.10 crore, and EPS of INR 115.51.
What is the book value of Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India has a book value of INR 150.93.
What is the debt-to-equity ratio of Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India has a price-to-book ratio of 26.38 and a price-to-sales ratio of 11.95.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.